VACCINEX, INC. (VCNX) › Shareholders' EquityVACCINEX, INC. (VCNX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$107.06M2017: -$113.49M2018: $15.34M2019: -$2.27M2020: -$2.61M2021: $7.41M2022: $5.19M2023: -$2.31M2024: -$2.49M-$2.49M2016Shareholders' Equity (USD)2024Fiscal YearShareholders' EquityChange YoY2024-$2.49M-7.7%2023-$2.31M-144.5%2022$5.19M-29.9%2021$7.41M+383.8%2020-$2.61M-14.9%2019-$2.27M-114.8%2018$15.34M+113.5%2017-$113.49M-6.0%2016-$107.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share